Article(id=1330127216941314265, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330127189372153867, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2018.02.014, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1510156800000, receivedDateStr=2017-11-09, revisedDate=1513353600000, revisedDateStr=2017-12-16, acceptedDate=null, acceptedDateStr=null, onlineDate=1795056641086, onlineDateStr=2026-11-19, pubDate=1518192000000, pubDateStr=2018-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795056641086, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795056641086, creator=13701087609, updateTime=1795056641086, updator=13701087609, issue=Issue{id=1330127189372153867, tenantId=1146029695717560320, journalId=1319690329412173987, year='2018', volume='39', issue='2', pageStart='S9', pageEnd='144', issueExtLink='null', onlineDate='null', pubDate='1518192000000', pubDateStr='2018-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795056634514, creator='13701087609', updateTime=1795056680728, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330127383656510048, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330127189372153867, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330127383656510049, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330127189372153867, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=S9, endPage=S13, ext={EN=ArticleExt(id=1330127217109086426, articleId=1330127216941314265, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress of panobinostat on multiple myeloma treatment, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=
Multiple myeloma (MM) is a common malignant blood tumor. Meantime, there is still no cure method and its recurrence rate is very high. Panobinostat is a histone deacetylase inhibitor (HDACi), which is used in MM treatment. This review summarizes the panobinostat used in MM treatment including its action mechanism against HDACi and its adverse reactions.
, authors=Xin-chi CHANG
1, Na NI
1, *, Xun-ting ZENG
1, *, Cui-cui SHI
1, Yu-han ZHAO
1, Yan CHEN
2, authorsList=Xin-chi CHANG, Na NI, Xun-ting ZENG, Cui-cui SHI, Yu-han ZHAO, Yan CHEN, authorCompany=null, correspAuthors=Na NI, Xun-ting ZENG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330127217486573787, articleId=1330127216941314265, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=多发性骨髓瘤治疗药物帕比司他的临床研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=
多发性骨髓瘤(MM)是一种血液系统常见的恶性肿瘤,目前仍无治愈方法且复发率很高。帕比司他(panobinostat)是一种组蛋白去乙酰化酶抑制剂(HDACi),用于治疗MM。本文从HDACi的作用机制与帕比司他的不良反应总结帕比司他对MM的临床疗效。
, authors=常新驰
1, 倪娜
1, *, 曾训庭
1, *, 石催催
1, 赵宇晗
1, 陈燕
2, authorsList=常新驰, 倪娜, 曾训庭, 石催催, 赵宇晗, 陈燕, authorCompany=null, correspAuthors=倪娜, 曾训庭, authorNote=
, correspAuthorsNote=
曾训庭,博士,副研究员,研究方向:临床药学,长期从事药物临床研究工作。
倪娜,硕士,研究方向:药物化学与临床药学,长期从事药物临床研究工作。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=iHomk+h0e6wSeAYrhqN5Xg==, magXml=gzfLBsLS6mVOZCD4PsNrIA==, pdfUrl=null, pdf=boHIBQ+KDg3J3eHlTMij5w==, pdfFileSize=932638, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=dzYHQaZuVX6Z0ff/FGijxg==, mapNumber=null, fund=null)}, authors=[Author(id=1330127217872449763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330127218023444709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, authorId=1330127217872449763, language=EN, stringName=Xin-chi CHANG, firstName=Xin-chi, middleName=null, lastName=CHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330127218090553574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, authorId=1330127217872449763, language=CN, stringName=常新驰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.中国医药工业研究总院药物临床研究中心,上海 200437, bio={"content":"
常新驰,硕士研究生,研究方向:临床药学。
"}, bioImg=null, bioContent=
常新驰,硕士研究生,研究方向:临床药学。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330127217654345948, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, xref=1., ext=[AuthorCompanyExt(id=1330127217666928861, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217654345948, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437), AuthorCompanyExt(id=1330127217671123166, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217654345948, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330127218166051048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330127218249937130, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, authorId=1330127218166051048, language=EN, stringName=Na NI, firstName=Na, middleName=null, lastName=NI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, *, address=
1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330127218367377643, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, authorId=1330127218166051048, language=CN, stringName=倪娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, *, address=
1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330127217654345948, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, xref=1., ext=[AuthorCompanyExt(id=1330127217666928861, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217654345948, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437), AuthorCompanyExt(id=1330127217671123166, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217654345948, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330127218468040941, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330127218530955503, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, authorId=1330127218468040941, language=EN, stringName=Xun-ting ZENG, firstName=Xun-ting, middleName=null, lastName=ZENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, *, address=
1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330127218585481456, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, authorId=1330127218468040941, language=CN, stringName=曾训庭, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, *, address=
1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330127217654345948, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, xref=1., ext=[AuthorCompanyExt(id=1330127217666928861, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217654345948, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437), AuthorCompanyExt(id=1330127217671123166, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217654345948, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330127218644201714, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330127218723893492, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, authorId=1330127218644201714, language=EN, stringName=Cui-cui SHI, firstName=Cui-cui, middleName=null, lastName=SHI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330127218782613749, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, authorId=1330127218644201714, language=CN, stringName=石催催, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330127217654345948, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, xref=1., ext=[AuthorCompanyExt(id=1330127217666928861, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217654345948, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437), AuthorCompanyExt(id=1330127217671123166, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217654345948, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330127218845528311, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330127218921025785, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, authorId=1330127218845528311, language=EN, stringName=Yu-han ZHAO, firstName=Yu-han, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330127218983940346, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, authorId=1330127218845528311, language=CN, stringName=赵宇晗, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330127217654345948, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, xref=1., ext=[AuthorCompanyExt(id=1330127217666928861, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217654345948, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437), AuthorCompanyExt(id=1330127217671123166, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217654345948, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330127219046854908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330127219118158078, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, authorId=1330127219046854908, language=EN, stringName=Yan CHEN, firstName=Yan, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330127220732965120, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, authorId=1330127219046854908, language=CN, stringName=陈燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330127217801146591, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, xref=2., ext=[AuthorCompanyExt(id=1330127217809535200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217801146591, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330127217817923809, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217801146591, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.上海瀛科隆医药开发有限公司,上海 200437)])])], keywords=[Keyword(id=1330127220858794241, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, language=EN, orderNo=1, keyword=multiple myeloma (MM)), Keyword(id=1330127220913320194, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, language=EN, orderNo=2, keyword=histone deacetylase inhibitors (HDACi)), Keyword(id=1330127220963651843, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, language=EN, orderNo=3, keyword=panobinostat), Keyword(id=1330127221026566404, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, language=CN, orderNo=1, keyword=多发性骨髓瘤(MM)), Keyword(id=1330127221089480965, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, language=CN, orderNo=2, keyword=组蛋白去乙酰化酶抑制剂(HDACi)), Keyword(id=1330127221194338566, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, language=CN, orderNo=3, keyword=帕比司他)], refs=[Reference(id=1330127221274030343, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=施淼颉, 刘澎. daratumumab治疗复发、难治性多发性骨髓瘤[J]. 世界临床药物, 2017, 38(3): 210-213., articleTitle=null, refAbstract=null), Reference(id=1330127221353722120, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=路瑾. 多发性骨髓瘤诊断标准的变迁及其对治疗的影响[J]. 中国肿瘤临床, 2014, 41(13): 819-822., articleTitle=null, refAbstract=null), Reference(id=1330127221412442377, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Adams J. The proteasome: a suitable antineoplastic target[J]. Nat Rev Cancer, 2004, 4(5): 349-360., articleTitle=null, refAbstract=null), Reference(id=1330127221483745546, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Roccaro AM, Hideshima T, Raje N,
et al. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells[J]. Camcer Res, 2006, 66(1): 184-191., articleTitle=null, refAbstract=null), Reference(id=1330127221555048715, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Richardson PG, Sonneveld P, Schuster MW,
et al. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma[J]. N Engl J Med, 2005, 352(24): 2487-2498., articleTitle=null, refAbstract=null), Reference(id=1330127221622157580, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Martínez-Iglesias O, Ruiz-Llorente L, Sánchez-Martínez R,
et al. Histone deacetylase inhibitors: mechanism of action nd therapeutic use in cancer[J]. Clin Transl Oncol, 2008, 10(7): 395-398., articleTitle=null, refAbstract=null), Reference(id=1330127221680877837, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Weber DM, Graef T, Hussein M,
et al. Phase Ⅰ trial of vorinostat combined with bortezomib for the treatment of relapsing and/or refractory multiple myeloma[J]. Clin Lymphoma Myeloma Leuk, 2012, 12(5): 319-324., articleTitle=null, refAbstract=null), Reference(id=1330127221743792398, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Richardson PG, Wolf J, Jakubowiak A,
et al. Perifosine plus bortezomib and dexamethasone in patients with relapsed / refractory multiple myeloma previously treated with bortezomib: results of a multicenter phase Ⅰ/Ⅱ trial[J]. J Clin Oncol, 2011, 29(32): 4243-4249., articleTitle=null, refAbstract=null), Reference(id=1330127221798318351, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Neri P, Tagliaferri P, Di Martino MT,
et al.
In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor[J]. Br J Haematol, 2008, 143(4): 520-531., articleTitle=null, refAbstract=null), Reference(id=1330127221865427216, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhao B, He T. Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer[J]. Oncol Rep, 2015, 33(1): 304-310., articleTitle=null, refAbstract=null), Reference(id=1330127221928341777, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Feng R, Ma H, Hassig CA,
et al. KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signaling[J]. Mol Cancer Ther, 2008, 7(6): 1494-1505., articleTitle=null, refAbstract=null), Reference(id=1330127221991256338, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Kitazoe K, Abe M, Hiasa M,
et al. Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma[J]. Int J Hematol, 2009, 89(1): 45-57., articleTitle=null, refAbstract=null), Reference(id=1330127222045782291, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=蔡博, 柳柏林, 高春记. 组蛋白去乙酰化酶抑制剂在多发性骨髓瘤治疗中的研究进展[J]. 解放军医学院学报, 2013, 34(5): 529-530., articleTitle=null, refAbstract=null), Reference(id=1330127222104502548, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Maes K, Menu E, Van Valckenborgh E,
et al. Epigenetic modulating agents as a new therapeutic approach in multiple myeloma[J]. Cancers, 2013, 5(2): 430-461., articleTitle=null, refAbstract=null), Reference(id=1330127222167417109, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Atadja p. Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges[J]. Cancer Lett, 2009, 280(2): 233-241., articleTitle=null, refAbstract=null), Reference(id=1330127222217748758, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Maiso P, Carvajal-Vergara X, Ocio EM,
et al. The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that oVercomes drug resistance[J]. Cancer Res, 2006, 66(11): 5781-5789., articleTitle=null, refAbstract=null), Reference(id=1330127222276469015, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=San-Miguel JF, Hungria VT, Yoon SS,
et al. Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsedand refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial[J]. Lancet Oncol, 2014, 15(11): 1195-1206., articleTitle=null, refAbstract=null), Reference(id=1330127222335189272, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Richardson P, Roy A, Suddhasatta A,
et al. Treatment-free interval as a metric of patient experience and a health outcome of value for advanced multiple myeloma: the case for the histone deacetylase inhibitor panobinostat, a next-generation novel agent[J]. Expert Rev Hematol, 2017, 10(10): 933-939., articleTitle=null, refAbstract=null), Reference(id=1330127222402298137, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Richardson PG, Schlossman RL, Alsina M,
et al. PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma[J]. Blood, 2013, 122(14): 2331-2337., articleTitle=null, refAbstract=null), Reference(id=1330127222469407002, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Richardson PG, Laubach JP, Lonial S,
et al. Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma[J]. Expert Rev Anticancer Ther, 2015, 15(7): 737-748., articleTitle=null, refAbstract=null), Reference(id=1330127222565875995, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Offidani M, Corvatta L, Liberati AM,
et al. Updated results of a phase 2 study of panobinostat combined with melphalan, thalidomide and prednisone (MPT) in relapsed/refractory multiple myeloma[J]. Leuk Lymphoma, 2017, 9(11): 1-3., articleTitle=null, refAbstract=null), Reference(id=1330127222641373468, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Popat R, Brown SR, Flanagan L,
et al. Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiplemyeloma (MUK-six): a multicentre, open-label, phase 1/2 trial[J]. Lancet Haematol, 2016, 3(12): e572-e580., articleTitle=null, refAbstract=null), Reference(id=1330127222700093725, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Majer I, van de Wetering G, Polanyi Z,
et al. Panobinostat plus bortezomib versus lenalidomide in patients with relapsed and/or refractory multiple myeloma: a matching-adjusted indirect treatment comparison of survival outcomesusing patient-level data[J]. Appl Health Econ Health Policy, 2017, 15(1): 45-55., articleTitle=null, refAbstract=null), Reference(id=1330127222771396894, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Baertsch MA, Hillengass J, Blocka J,
et al. Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practice[J]. Hematol Oncol, 2017, doi: 10.1002/hon.2462., articleTitle=null, refAbstract=null), Reference(id=1330127222846894367, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Sharma S, Beck J, Mita M,
et al. A phase Ⅰ dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors[J]. Invest New Drugs, 2013, 31(4): 974-985., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330127217654345948, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, xref=1., ext=[AuthorCompanyExt(id=1330127217666928861, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217654345948, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437), AuthorCompanyExt(id=1330127217671123166, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217654345948, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.中国医药工业研究总院药物临床研究中心,上海 200437)]), AuthorCompany(id=1330127217801146591, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, xref=2., ext=[AuthorCompanyExt(id=1330127217809535200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217801146591, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330127217817923809, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330127216941314265, companyId=1330127217801146591, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.上海瀛科隆医药开发有限公司,上海 200437)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.02.014, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.02.014, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2018.02.014, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2018.02.014, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1518192000000, fullTextJson=null, articleText=null, reference=null)